Plasma Bioscience Research Center, Department of Electrical and Biological Physics, Kwangwoon University, Seoul, 01897, South Korea.
Department of Biotechnology, College of Engineering, The University of Suwon, Hwaseong, 18323, South Korea.
Free Radic Biol Med. 2024 Sep;222:1-15. doi: 10.1016/j.freeradbiomed.2024.05.033. Epub 2024 May 18.
Non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma (LUAD), significantly influences cancer-related mortality and is frequently considered by poor therapeutic responses due to genetic alterations. Cancer cells possess an inclination to develop resistance to individual treatment modalities, thus it is necessary to investigate several pathways simultaneously to obtain insights that will aid in the establishment of improved therapeutic approaches. Exploring regulated cell death (RCD) mechanisms offers promising avenues to augment immunotherapy by reshaping the tumor microenvironment (TME). Here, we investigated the prospective of microwave plasma-infused nitric oxide water (NOW) to initiate immunogenic cell death (ICD) while concurrently modulating autophagy and ferroptosis signaling in LUAD-associated A549 cells. Plasma treatment results in stable NO species nitrite/nitrate (NO/NO) in the water, altering its physicochemical properties. Analysis of ICD markers reveals increased expression of damage-associated molecular patterns (DAMPs) at both protein and mRNA levels post-NOW exposure. Intracellular reactive oxygen and nitrogen species (RONS) accumulation suggests NO-mediated mitochondrial dysfunction, triggering autophagy induction. Flow cytometry and western blotting confirm alterations in autophagy regulators Beclin 1 and SQSTM1. Furthermore, NOW treatment induces lipid peroxidation and upregulates ferroptosis-associated genes, as determined by qRT-PCR. Transmission electron microscopy (TEM) imaging reveals autophagosome formation and loss of cristae structures, corroborating the occurrence of autophagy and ferroptosis. Our findings propose that NOW may considered as inducer of ICD and the stimulation of other RCD-related proteins may enhance the anti-tumor immunogenicity.
非小细胞肺癌(NSCLC),尤其是肺腺癌(LUAD),显著影响癌症相关死亡率,并且由于遗传改变,常被认为治疗反应不佳。癌细胞有倾向对单一治疗方式产生耐药性,因此有必要同时研究几种途径,以获得有助于建立改进治疗方法的见解。探索受调控的细胞死亡(RCD)机制为通过重塑肿瘤微环境(TME)增强免疫疗法提供了有前途的途径。在这里,我们研究了微波等离子体注入的一氧化氮水(NOW)引发免疫原性细胞死亡(ICD)的潜力,同时调节 LUAD 相关 A549 细胞中的自噬和铁死亡信号。等离子体处理导致水中稳定的 NO 物质亚硝酸盐/硝酸盐(NO/NO),改变其理化性质。ICD 标志物分析显示,NOW 暴露后 DAMPs 在蛋白质和 mRNA 水平的表达增加。细胞内活性氧和氮物质(RONS)的积累表明 NO 介导的线粒体功能障碍,触发自噬诱导。流式细胞术和 Western blot 证实自噬调节剂 Beclin 1 和 SQSTM1 的变化。此外,NOW 处理诱导脂质过氧化并上调铁死亡相关基因,这通过 qRT-PCR 确定。透射电子显微镜(TEM)成像显示自噬体的形成和嵴结构的丢失,证实了自噬和铁死亡的发生。我们的研究结果表明,NOW 可能被认为是 ICD 的诱导剂,刺激其他 RCD 相关蛋白可能增强抗肿瘤免疫原性。